A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)

Clinical trial NCT05230459 · RECRUITING

Trial details

NCT number: NCT05230459
Sponsor: AskBio Inc
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Limb Girdle Muscular Dystrophy Limb-Girdle Muscular Dystrophy Type 2 LGMD2I Muscular Dystrophy LGMD2 LGMD FKRP FKRP Mutation Fukutin Related Protein

Start date: 2023-05-15
Primary completion: 2028-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.